Welcome to Sun-shine chemical
+86-17702719238 sales@sun-shinechem.com

Products

Catalog NoChemical NameCAS NumberPurityChemical Structure
010802LX71011192189-69-798% 
LX7101 is a potent inhibitor of LIMK1/2, ROCK2 and PKA, with IC50 of 24/1.6, 10, and
010435Loratadine79794-75-598% 
Loratadine is a selective inverse peripheral histamine H1-receptor agonist with an IC
122909LY2584702 free base1082949-67-498% 
LY2584702 is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and p
122907LY2584702 tosylate1082949-68-598% 
LY-2584702 tosylate salt is an orally available inhibitor of p70S6K signaling; inhibi
122835L-779450303727-31-398% 
L-779450 is a potent, selective and ATP-competitive Raf kinase inhibitor (IC50 = 10 n
122830LDN193189 Hydrochloride1062368-62-098%
LDN193189 Hydrochloride is a selective BMP signaling inhibitor, inhibits the transcri
122820LCL1611005342-46-098% 
LCL161 is an orally bioavailable SMAC mimetic and inhibitor of Inhibitor of Apoptosis
122803Lexibulin917111-44-598% 
Lexibulin is an orally bioavailable small-molecule with tubulin-inhibiting, vascular-
122509LY2228820862507-23-198% 
LY2228820 is a novel and potent p38MAPK inhibitor (the IC50 for p38MAPK and p38MAPK w
122218LY26082041234703-40-298% 
LY2608204 is a activator of glucokinase (GK) with EC50 of 42 nM.
121805L-778123 hydrochloride253863-00-298%
L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and
121506Laquinimod248281-84-798% 
Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva.
121435LY28113761194044-20-698% 
LY2811376 is a BACE1 inhibitor with marked Ab-lowering effects in animal models.
121427LY28867211262036-50-998% 
LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.
121416Linifanib796967-16-398% 
Linifanib is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR, CSF-1R, F
5121102LY2090314603288-22-898% by HPLC 
LY2090314 (LY) is a glycogen synthase kinase 3 inhibitor with preclinical efficacy in
120422LMK 2351418033-25-698% 
LMK 235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor, which demons
110606LDN-57444668467-91-298% 
LDN-57444 is a Uch-L1 inhibitor with Ki= 0.4 M. Ubiquitin carboxy-terminal hydrolase
110603Leuprolide53714-56-098% 
Leuprolide is an agonist at pituitary GnRH receptors.
101914LY2409881 trihydrochloride946518-60-198% 
LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM;
91810LHW090-A71308256-94-198% 
Coming soon!
91001L18964232-83-398% 
L189 inhibits base excision repair (BER) and non-homologous end joining (NHEJ), which
82608Linagliptin668270-12-098% 
Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.
81313Lurasidone hydrochloride367514-87-298% 
Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma, which
81001LRRK2-IN-11234480-84-297% 
LRRK2-IN-1 is a cell-permeable, ATP competitive, potent, and selective LRRK2 inhibito
71801LY28744551254473-64-798% 
1) Sponsor: Eli Lilly and Company.2) Phase:Phase 12) LY2874455 is potent, selective,
52806LDK3781032900-25-698% 
LDK378(Ceritinib) is potent inhibitor against ALK with IC50 of 0.2 nM, shows 40- and
52733LDN1931891062368-24-498% 
LDN193189(DM 3189) is a selective BMP signaling inhibitor, inhibits the transcription
52721Lorcaserin Hydrochloride846589-98-898% 
Lorcaserin HCl(APD-356 Hcl) is a selective full agonist of human 5-HT2C receptor with
52707LDN-2141171627503-67-698% 
LDN-214117 is a potent and selective ALK2 inhibitor with IC50 of 22 nM; > 100 fold